Unenhanced MRI of the abdomen and pelvis for surveillance of patients with stage 1 testicular cancer post-radical orchie

  • PDF / 658,010 Bytes
  • 6 Pages / 595.276 x 790.866 pts Page_size
  • 53 Downloads / 112 Views

DOWNLOAD

REPORT


KIDNEYS, URETERS, BLADDER, RETROPERITONEUM

Unenhanced MRI of the abdomen and pelvis for surveillance of patients with stage 1 testicular cancer post‑radical orchiectomy Rishi Narine1 · Heba Osman1 · Sirote Wongwaisayawan1 · Scott Morgan2 · Luke T. Lavallee3 · Nicola Schieda4  Received: 1 June 2020 / Revised: 11 August 2020 / Accepted: 21 August 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020

Abstract Objective  To evaluate the ability of unenhanced magnetic resonance imaging (MRI) to detect metastatic lymphadenopathy in men with stage 1 testicular cancer on surveillance. Materials and methods  With IRB approval, we identified 23 consecutive men with stage 1 testicular cancer (diagnosed after orchiectomy) undergoing surveillance with unenhanced MRI of the abdomen and pelvis. Three blinded radiologists (2 inexperienced R1/R2 and 1 experienced R3) independently assessed MRI for: presence, location and size of abnormal lymph nodes and degree of confidence (5-point Likert scale) in diagnosis. Diagnostic accuracy was tabulated and compared between groups using ROC. Inter-observer agreement was assessed using Cohen’s kappa statistic. Results  17.4% (4/23) men developed 6 metastatic lymph nodes (reference standard: interval development from baseline, size > 1.0 cm short axis). R1 and R2 detected 75% (3/4) patients with abnormal lymph nodes, compared to R3 who detected all four cases. False positive interpretations occurred in: 5.2% (1/19) R1, 10.5% (2/19) R2 and no patients for R3. Sensitivity, specificity and area under the ROC curve (AUC) were: R1: 75% (95% CI 19.4–99.4%), 94.7% (74.0–99.9%) and 0.85 (0.59–1.00), R2: 75% (19.4–99.4%), 89.5% (66.9–98.7%) and 0.82 (0.57–1.00) and, R3: 100% (95% 39.8–100.0%), 100% (82.4–100%) and 1.00 (1.00–1.00) with no difference in AUC between readers (p = 0.383). Comparison in accuracy between readers is limited due to the small sample size. Inter-observer agreement was substantial (K = 0.62). Median (range) degree of confidence scores were rated: R1 5 (5–5), R2 4 (3–5) and, R3 5 (5–5). Conclusion  In this study, unenhanced MRI was adequate for surveillance of stage 1 testicular cancer; however, radiologist inexperience may lead to errors. Keywords  Testicular cancer · Seminoma · Surveillance · Lymph nodes · MRI

Electronic supplementary material  The online version of this article (https​://doi.org/10.1007/s0026​1-020-02715​-z) contains supplementary material, which is available to authorized users.

Abbreviations MRI Magnetic resonance imaging CT Computed Tomography R Radiologist

* Nicola Schieda [email protected]

1



Department of Medical Imaging, The Ottawa Hospital, Ottawa, ON, Canada

Rishi Narine [email protected]

2



Division of Radiation Oncology, Department of Medical Imaging, The Ottawa Hospital, Ottawa, ON, Canada

Heba Osman [email protected]

3



Division of Urology, Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada

Sirote Wongwaisayawan [email protected]

4



Department of Medical Imaging, The Ottawa Hospital, 1053